US 9217024
ADDL receptor polypeptides, polynucleotides and host cells for recombinant production
granted A61PA61P25/00A61P25/28
Quick answer
US patent 9217024 (ADDL receptor polypeptides, polynucleotides and host cells for recombinant production) held by Acumen Pharmaceuticals, Inc. expires Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Acumen Pharmaceuticals, Inc.
- Grant date
- Tue Dec 22 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 17 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 27
- CPC classes
- A61P, A61P25/00, A61P25/28